Previous close | 0.1498 |
Open | 0.1498 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.1406 - 0.1498 |
52-week range | 0.1400 - 0.4936 |
Volume | |
Avg. volume | 130,484 |
Market cap | 7.966M |
Beta (5Y monthly) | 2.44 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1100 |
Earnings date | 11 Sept 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.80 |
PARIS & BOULDER, Colo., July 17, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces the filing of its "510K" regulatory dossier in the US with the FDA, seeking clearance to commercialize its new device designed to secure the Posterior sacroiliac Fusion (PsiF) surgical procedure.
PARIS & BOULDER, Colo., July 15, 2024--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2024 revenue.
PARIS & BOULDER, Colo., June 26, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, publishes on its Annual Shareholders’ Meeting held on Wednesday June 26, 2024, convened on the second notice at the offices of the law firm Ashurst Paris, located at 18 square Edouard VII, 75009 Paris.